Intravenous ascorbic acid: protocol for its application and use

P R Health Sci J. 2003 Sep;22(3):287-90.

Abstract

High dose intravenous(i.v.) ascorbic acid (AA) has been used as therapy for infectious disease from bacterial and viral origin and adjuvant therapy for cancer. In this publication we describe a clinical protocol that has been developed over the past twenty years utilizing high dose i.v. AA as therapy for cancer. This includes principles of treatment, rationale, baseline workup, infusion protocol, precautions and side effects.

MeSH terms

  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / adverse effects
  • Anti-Infective Agents / therapeutic use
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Ascorbic Acid / administration & dosage*
  • Ascorbic Acid / adverse effects
  • Ascorbic Acid / pharmacology
  • Ascorbic Acid / therapeutic use
  • Bacterial Infections / drug therapy
  • Clinical Protocols
  • Dose-Response Relationship, Drug
  • Humans
  • Infusions, Intravenous
  • Neoplasms / drug therapy
  • Neoplastic Stem Cells / drug effects
  • Virus Diseases / drug therapy

Substances

  • Anti-Infective Agents
  • Antineoplastic Agents
  • Ascorbic Acid